Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- EPL:
-
Expressed protein ligation
- NCL:
-
Native chemical ligation
- PrP:
-
Prion protein
- PrPC :
-
The cellular isoform of prion protein
- PrPSc :
-
The pathogenic or scrapie isoform of prion protein
- PTS:
-
Protein trans splicing
- rPrP:
-
Recombinant prion protein
- SPPS:
-
Solid phase peptide synthesis
- TEV:
-
Tobacco etch virus
- TSE:
-
Transmissible spongiform encephalopathy
References
Fischer E (1894) Einfluss der Konfiguration auf die Wirkung der Enzyme. Ber Dtsch Chem Ges 27:2985–2993
du Vigneaud V, Ressler C, Swan JM, Roberts CW, Katsoyannis PG (1954) The synthesis of oxytocin. J Am Chem Soc 76:3115–3121
Meienhofer J, Schnabel E, Bremer H, Brinkhoff O, Zabel R, Sroka W, Klostermeyer H, Brandenburg D, Okuda T, Zahn H (1963) Synthese der Insulinketten und Ihre Kombination zu Insulinaktiven Präparaten. Z Naturforschung B 18:1120–1121
Katsoyannis PG, Fukuda K, Tometsko A, Suzuki K, Tilak M (1964) Insulin peptides. X. The synthesis of the B-chain of insulin and its combination with natural or synthetis A-chin to generate insulin activity. J Am Chem Soc 86:930–932
Barany G, Merrifield RB (1980) Solid phase peptide synthesis. In: Gross E, Meienhofer J (eds) The peptides analysis, synthesis, biology, vol 2. Academic, New York, pp 3–284
Merrifield RB (1963) Solid phase peptide synthesis. 1. Synthesis of tetrapeptide. J Am Chem Soc 85:2149–2154
Dawson PE, Muir TW, Clark-Lewis I, Kent SBH (1994) Synthesis of proteins by native chemical ligation. Science 266:776–779
Dawson PE, Kent SBH (2000) Synthesis of native proteins by chemical ligation. Annu Rev Biochem 69:923–960
Muir TW, Sondhi D, Cole PA (1998) Expressed protein ligation: a general method for protein engineering. Proc Natl Acad Sci USA 95:6705–6710
Muir TW (2003) Semisynthesis of proteins by expressed protein ligation. Annu Rev Biochem 72:249–289
Barany G, Merrifield RB (1977) New amino protecting group removable by reduction – chemistry of dithiasuccinoyl (dts) function. J Am Chem Soc 99:7363–7365
Stewart JM, Young JD (1984) Solid phase peptide synthesis. Pierce Chemical Company, Rockford
Wieland T, Bokelmann E, Bauer L, Lang HU, Lau H (1953) *Uber Peptidsynthesen.8. Bildung Von S-Haltigen Peptiden Durch Intramolekulare Wanderung Von Aminoacylresten. Annalen der Chemie-Justus Liebig 583:129–149
Baca M, Muir TW, Schnölzer M, Kent SBH (1995) Chemical ligation of cysteine-containing peptides: synthesis of a 22 kDa tethered dimer of HIV-1 protease. J Am Chem Soc 117:1881–1887
Becker CFW, Hunter CL, Seidel R, Kent SBH, Goody RS, Engelhard M (2003) Total chemical synthesis of a functional interacting protein pair: the protooncogene H-Ras and the Ras-binding domain of its effector c-Raf1. PNAS 100:5075–5080
Durek T, Torbeev VY, Kent SBH (2007) Convergent chemical synthesis and high-resolution X-ray structure of human lysozyme. PNAS 104:4846–4851
Pentelute BL, Mandal K, Gates ZP, Sawaya MR, Yeates TO, Kent SBH (2010) Total chemical synthesis and X-ray structure of kaliotoxin by racemic protein crystallography. Chem Commun 46:8174–8176
Bang D, Pentelute BL, Kent SBH (2006) Kinetically controlled ligation for the convergent chemical synthesis of proteins. Angew Chem (Engl) 45:3985–3988
Chakrabarti O, Ashok A, Hegde RS (2009) Prion protein biosynthesis and its emerging role in neurodegeneration. Trends Biochem Sci 34:287–295
Tatzelt J, Winklhofer KF (2004) Folding and misfolding of the prion protein in the secretory pathway. Amyloid 11:162–172
Jurica MS, Stoddard BL (1999) Homing endonucleases: structure, function and evolution. Cell Mol Life Sci 55:1304–1326
Stoddard BL (2005) Homing endonuclease structure and function. Q Rev Biophys 38:49–95
Noren CJ, Wang JM, Perler FB (2000) Dissecting the chemistry of protein splicing and its applications. Angew Chem Int Ed Engl 39:451–466
Pereira B, Shemella PT, Amitai G, Belfort G, Nayak SK, Belfort M (2011) Spontaneous proton transfer to a conserved intein residue determines on-pathway protein splicing. J Mol Biol 406:430–442
Caspi J, Amitai G, Belenkiy O, Pietrokovski S (2003) Distribution of split DnaE inteins in cyanobacteria. Mol Microbiol 50:1569–1577
Paulus H (2000) Protein splicing and related forms of protein autoprocessing. Annu Rev Biochem 69:447–496
Mootz HD, Blum ES, Tyszkiewicz AB, Muir TW (2003) Conditional protein splicing: a new tool to control protein structure and function in vitro and in vivo. J Am Chem Soc 125:10561–10569
Pellois JP, Muir TW (2005) A ligation and photorelease strategy for the temporal and spatial control of protein function in living cells. Angew Chem (Engl) 44:5713–5717
Deisseroth K (2011) Optogenetics. Nat Methods 8:26–29
Stahl N, Prusiner SB (1991) Prions and prion proteins. FASEB J 5:2799–2807
Winklhofer KF, Tatzelt J, Haass C (2008) The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases. EMBO J 27:336–349
Kaneko K, Peretz D, Pan KM, Blochberger TC, Wille H, Gabizon R, Griffith OH, Cohen FE, Baldwin MA, Prusiner SB (1995) Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform. Proc Natl Acad Sci USA 92:11160–11164
Zhang H, Kaneko K, Nguyen JT, Livshits TL, Baldwin MA, Cohen FE, James TL, Prusiner SB (1995) Conformational transitions in peptides containing two putative alpha-helices of the prion protein. J Mol Biol 250:514–526
Kaneko K, Ball HL, Wille H, Zhang H, Groth D, Torchia M, Tremblay P, Safar J, Prusiner SB, DeArmond SJ, Baldwin MA, Cohen FE (2000) A synthetic peptide initiates Gerstmann-Straussler-Scheinker (GSS) disease in transgenic mice. J Mol Biol 295:997–1007
Ball HL, King DS, Cohen FE, Prusiner SB, Baldwin MA (2001) Engineering the prion protein using chemical synthesis. J Pept Res 58:357–374
Olschewski D, Seidel R, Miesbauer M, Rambold AS, Oesterhelt D, Winklhofer KF, Tatzelt J, Engelhard M, Becker CF (2007) Semisynthetic murine prion protein equipped with a GPI anchor mimic incorporates into cellular membranes. Chem Biol 14:994–1006
Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, Wüthrich K (1996) NMR structure of the mouse prion protein domain PrP(121–231). Nature 382:180–182
Schumacher MC, Resenberger U, Seidel RP, Becker CF, Winklhofer KF, Oesterhelt D, Tatzelt J, Engelhard M (2010) Synthesis of a GPI anchor module suitable for protein post-translational modification. Biopolymers 94:457–464
Heller U, Winklhofer KF, Heske J, Reintjes A, Tatzelt J (2003) Post-translational import of the prion protein into the endoplasmic reticulum interferes with cell viability: a critical role for the putative transmembrane domain. J Biol Chem 278:36139–36147
Li A, Dong J, Harris DA (2004) Cell surface expression of the prion protein in yeast does not alter copper utilization phenotypes. J Biol Chem 279:29469–29477
Dhar T, Mootz HD (2011) Modification of transmembrane and GPI-anchored proteins on living cells by efficient protein trans-splicing using the Npu DnaE intein. Chem Commun 47:3063–3065
Becker CF, Liu X, Olschewski D, Castelli R, Seidel R, Seeberger PH (2008) Semisynthesis of a glycosylphosphatidylinositol-anchored prion protein. Angew Chem Int Ed Engl 47:8215–8219
Chu NK, Becker CF (2009) Semisynthesis of membrane-attached prion proteins. Methods Enzymol 462:177–193
Kiessling LL, Splain RA (2010) Chemical approaches to glycobiology. Annu Rev Biochem 79:619–653
Greene LE, Park YN, Masison DC, Eisenberg E (2009) Application of GFP-labeling to study prions in yeast. Protein Pept Lett 16:635–641
Kawai-Noma S, Ayano S, Pack CG, Kinjo M, Yoshida M, Yasuda K, Taguchi H (2006) Dynamics of yeast prion aggregates in single living cells. Genes Cells 11:1085–1096
Giese A, Bieschke J, Eigen M, Kretzschmar HA (2000) Putting prions into focus: application of single molecule detection to the diagnosis of prion diseases. Arch Virol Suppl 161–171
Kawai-Noma S, Pack CG, Kojidani T, Asakawa H, Hiraoka Y, Kinjo M, Haraguchi T, Taguchi H, Hirata A (2010) In vivo evidence for the fibrillar structures of Sup35 prions in yeast cells. J Cell Biol 190:223–231
Sakata H, Horiuchi M, Takahashi I, Kinjo M (2010) Conformational analysis of soluble oligomers of GFP tagged prion protein by fluorescence fluctuation spectroscopy. Curr Pharm Biotechnol 11:87–95
Medrano AZ, Barmada SJ, Biasini E, Harris DA (2008) GFP-tagged mutant prion protein forms intra-axonal aggregates in transgenic mice. Neurobiol Dis 31:20–32
Wu YX, Masison DC, Eisenberg E, Greene LE (2006) Application of photobleaching for measuring diffusion of prion proteins in cytosol of yeast cells. Methods 39:43–49
Vasiljevic S, Ren J, Yao Y, Dalton K, Adamson CS, Jones IM (2006) Green fluorescent protein as a reporter of prion protein folding. Virol J 3:59
Scheibel T, Bloom J, Lindquist SL (2004) The elongation of yeast prion fibers involves separable steps of association and conversion. PNAS 101:2287–2292
Wildegger G, Liemann S, Glockshuber R (1999) Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates. Nat Struct Biol 6:550–553
Sun Y, Breydo L, Makarava N, Yang Q, Bocharova OV, Baskakov IV (2007) Site-specific conformational studies of prion protein (PrP) amyloid fibrils revealed two cooperative folding domains within amyloid structure. J Biol Chem 282:9090–9097
Dong J, Castro CE, Boyce MC, Lang MJ, Lindquist S (2010) Optical trapping with high forces reveals unexpected behaviors of prion fibrils. Nat Struct Mol Biol 17:1422–1430
Ernst RR (1992) Nobel lecture. Nuclear magnetic resonance Fourier transform spectroscopy. Biosci Rep 12:143–187
Wüthrich K (2003) NMR studies of structure and function of biological macromolecules (Nobel lecture). Angew Chem Int Ed Engl 42:3340–3363
Renault M, Cukkemane A, Baldus M (2010) Solid-state NMR spectroscopy on complex biomolecules. Angew Chem Int Ed 49:8346–8357
Lysek DA, Schorn C, Nivon LG, Esteve-Moya V, Christen B, Calzolai L, von Schroetter C, Fiorito F, Herrmann T, Guntert P, Wüthrich K (2005) Prion protein NMR structures of cats, dogs, pigs, and sheep. Proc Natl Acad Sci USA 102:640–645
Calzolai L, Lysek DA, Perez DR, Guntert P, Wüthrich K (2005) Prion protein NMR structures of chickens, turtles, and frogs. Proc Natl Acad Sci USA 102:651–655
Gossert AD, Bonjour S, Lysek DA, Fiorito F, Wüthrich K (2005) Prion protein NMR structures of elk and of mouse/elk hybrids. Proc Natl Acad Sci USA 102:646–650
Christen B, Wüthrich K, Hornemann S (2008) Putative prion protein from fugu (Takifugu rubripes). FEBS J 275:263–270
Perez DR, Damberger FF, Wüthrich K (2010) Erratum to “Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein” [J Mol Biol 400/2 (2010) 121–128]. J Mol Biol 402:929–930
Perez DR, Damberger FF, Wüthrich K (2010) Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein. J Mol Biol 400:121–128
Ilc G, Giachin G, Jaremko M, Jaremko L, Benetti F, Plavec J, Zhukov I, Legname G (2010) NMR structure of the human prion protein with the pathological Q212P mutation reveals unique structural features. PLoS One 5:e11715
Tycko R (2011) Solid-state NMR studies of amyloid fibril structure. Annu Rev Phys Chem 62:279–299
Cobb NJ, Sonnichsen FD, McHaourab H, Surewicz WK (2007) Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc Natl Acad Sci USA 104:18946–18951
Lu X, Wintrode PL, Surewicz WK (2007) Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange. Proc Natl Acad Sci USA 104:1510–1515
Helmus JJ, Surewicz K, Surewicz WK, Jaroniec CP (2010) Conformational flexibility of Y145Stop human prion protein amyloid fibrils probed by solid-state nuclear magnetic resonance spectroscopy. J Am Chem Soc 132:2393–2403
Helmus JJ, Surewicz K, Nadaud PS, Surewicz WK, Jaroniec CP (2008) Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils. Proc Natl Acad Sci USA 105:6284–6289
Shewmaker F, Kryndushkin D, Chen B, Tycko R, Wickner RB (2009) Two prion variants of Sup35p have in-register parallel beta-sheet structures, independent of hydration. Biochemistry 48:5074–5082
Perutz MF, Johnson T, Suzuki M, Finch JT (1994) Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci USA 91:5355–5358
Wasmer C, Lange A, Van Melckebeke H, Siemer AB, Riek R, Meier BH (2008) Amyloid fibrils of the HET-s(218–289) prion form a beta solenoid with a triangular hydrophobic core. Science 319:1523–1526
Bockmann A, Meier BH (2010) Prions: en route from structural models to structures. Prion 4:72–79
Altenbach C, Marti T, Khorana HG, Hubbell WL (1990) Transmembrane protein structure: spin labeling of bacteriorhodopsin mutants. Science 248:1088–1092
Altenbach C, Flitsch SL, Khorana HG, Hubbell WL (1989) Structural studies on transmembrane proteins. 2. Spin labeling of bacteriorhodopsin mutants at unique cysteines. Biochemistry 28:7806–7812
Klare J, Steinhoff H-J (2009) Spin labeling EPR. Photosynth Res 102:377–390
Klug CS, Feix JB (2008) Methods and applications of site-directed spin labeling EPR spectroscopy. Methods Cell Biol 84:617–658
Drew SC, Barnham KJ (2008) Biophysical investigations of the prion protein using electron paramagnetic resonance. Methods Mol Biol 459:173–196
Lundberg KM, Stenland CJ, Cohen FE, Prusiner SB, Millhauser GL (1997) Kinetics and mechanism of amyloid formation by the prion protein H1 peptide as determined by time-dependent ESR. Chem Biol 4:345–355
Uversky VN, Dunker AK (2010) Understanding protein non-folding. Biochim Biophys Acta 1804:1231–1264
He B, Wang K, Liu Y, Xue B, Uversky VN, Dunker AK (2009) Predicting intrinsic disorder in proteins: an overview. Cell Res 19:929–949
Dunker AK, Brown CJ, Lawson JD, Iakoucheva LM, Obradovic Z (2002) Intrinsic disorder and protein function. Biochemistry 41:6573–6582
Kozlowski H, Luczkowski M, Remelli M (2010) Prion proteins and copper ions. Biological and chemical controversies. Dalton Trans 39:6371–6385
Brown DR (2011) Prions and manganese: a maddening beast. Metallomics 3:229–238
Hornshaw MP, McDermott JR, Candy JM, Lakey JH (1995) Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem Biophys Res Commun 214:993–999
Hornshaw MP, McDermott JR, Candy JM (1995) Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem Biophys Res Commun 207:621–629
Chattopadhyay M, Walter ED, Newell DJ, Jackson PJ, Aronoff-Spencer E, Peisach J, Gerfen GJ, Bennett B, Antholine WE, Millhauser GL (2005) The octarepeat domain of the prion protein binds Cu(II) with three distinct coordination modes at pH 7.4. J Am. Chem Soc 127:12647–12656
Jones CE, Klewpatinond M, Abdelraheim SR, Brown DR, Viles JH (2005) Probing copper2+ binding to the prion protein using diamagnetic nickel2+ and 1 H NMR: the unstructured N terminus facilitates the coordination of six copper2+ ions at physiological concentrations. J Mol Biol 346:1393–1407
Jones CE, Abdelraheim SR, Brown DR, Viles JH (2004) Preferential Cu2+ coordination by His96 and His111 induces beta-sheet formation in the unstructured amyloidogenic region of the prion protein. J Biol Chem 279:32018–32027
Masuoka J, Hegenauer J, Van Dyke BR, Saltman P (1993) Intrinsic stoichiometric equilibrium constants for the binding of zinc(II) and copper(II) to the high affinity site of serum albumin. J Biol Chem 268:21533–21537
Joergstuerenburg H, Oechsner M, Schroeder S, Kunze K (1999) Determinants of the copper concentration in cerebrospinal fluid. J Neurol Neurosurg Psychiatry 67:252–253
Charveriat M, Reboul M, Wang Q, Picoli C, Lenuzza N, Montagnac A, Nhiri N, Jacquet E, Gueritte F, Lallemand JY, Deslys JP, Mouthon F (2009) New inhibitors of prion replication that target the amyloid precursor. J Gen Virol 90:1294–1301
Guo K, Mutter R, Heal W, Reddy TR, Cope H, Pratt S, Thompson MJ, Chen B (2008) Synthesis and evaluation of a focused library of pyridine dicarbonitriles against prion disease. Eur J Med Chem 43:93–106
Bertsch U, Winklhofer KF, Hirschberger T, Bieschke J, Weber P, Hartl FU, Tavan P, Tatzelt J, Kretzschmar HA, Giese A (2005) Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets. J Virol 79:7785–7791
Bolognesi ML, Ai Tran HN, Staderini M, Monaco A, Lopez-Cobenas A, Bongarzone S, Biarnes X, Lopez-Alvarado P, Cabezas N, Caramelli M, Carloni P, Menendez JC, Legname G (2010) Discovery of a class of diketopiperazines as antiprion compounds. ChemMedChem 5:1324–1334
Feng BY, Toyama BH, Wille H, Colby DW, Collins SR, May BC, Prusiner SB, Weissman J, Shoichet BK (2008) Small-molecule aggregates inhibit amyloid polymerization. Nat Chem Biol 4:197–199
Winklhofer KF, Tatzelt J (2000) Cationic lipopolyamines induce degradation of PrPSc in scrapie-infected mouse neuroblastoma cells. Biol Chem 381:463–469
Rambold AS, Miesbauer M, Olschewski D, Seidel R, Riemer C, Smale L, Brumm L, Levy M, Gazit E, Oesterhelt D, Baier M, Becker CF, Engelhard M, Winklhofer KF, Tatzelt J (2008) Green tea extracts interfere with the stress-protective activity of PrP(C) and the formation of PrP(Sc). J Neurochem 107:218–229
Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, Engemann S, Pastore A, Wanker EE (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15:558–566
Roberts BE, Duennwald ML, Wang H, Chung C, Lopreiato NP, Sweeny EA, Knight MN, Shorter J (2009) A synergistic small-molecule combination directly eradicates diverse prion strain structures. Nat Chem Biol 5:936–946
Porat Y, Mazor Y, Efrat S, Gazit E (2004) Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions. Biochemistry 43:14454–14462
Frid P, Anisimov SV, Popovic N (2007) Congo red and protein aggregation in neurodegenerative diseases. Brain Res Rev 53:135–160
Alavez S, Vantipalli MC, Zucker DJS, Klang IM, Lithgow GJ (2011) Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan. Nature 472:226–229
Brandner S, Raeber A, Sailer A, Blattler T, Fischer M, Weissmann C, Aguzzi A (1996) Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. Proc Natl Acad Sci USA 93:13148–13151
Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302:871–874
Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, Caughey B, Masliah E, Oldstone M (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308:1435–1439
Rambold AS, Muller V, Ron U, Ben-Tal N, Winklhofer KF, Tatzelt J (2008) Stress-protective signalling of prion protein is corrupted by scrapie prions. EMBO J 27:1974–1984
Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-ß oligomers. Nature 457:1128–1132
Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Lauren J, Gimbel ZA, Strittmatter SM (2010) Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 30:6367–6374
Chen S, Yadav SP, Surewicz WK (2010) Interaction between human prion protein and amyloid-ß (Aß) oligomers. J Biol Chem 285:26377–26383
Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Muller V, Krishnan R, Vabulas RM, Kretzschmar HA, Lindquist S, Hartl FU, Multhaup G, Winklhofer KF, Tatzelt J (2011) The cellular prion protein mediates neurotoxic signalling of ß-sheet-rich conformers independent of prion replication. EMBO J 30:2057–2070
Olzscha H, Schermann SM, Woerner AC, Pinkert S, Hecht MH, Tartaglia GG, Vendruscolo M, Hayer-Hartl M, Hartl FU, Vabulas RM (2011) Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144:67–78
Acknowledgement
Our work was supported by Max Planck Society. We would like to thank Frederieke Itzen, Claudia Pieczka, and Marc Dittmann for preparation of the figures and Florian Seebeck for critically reading the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Seidel, R., Engelhard, M. (2011). Chemical Biology of Prion Protein: Tools to Bridge the In Vitro/Vivo Interface. In: Tatzelt, J. (eds) Prion Proteins. Topics in Current Chemistry, vol 305. Springer, Berlin, Heidelberg. https://doi.org/10.1007/128_2011_201
Download citation
DOI: https://doi.org/10.1007/128_2011_201
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-24066-9
Online ISBN: 978-3-642-24067-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)